SRC
HOLX

Shufro Rose & Co’s Hologic HOLX Stock Holding History

Shufro Rose & Co’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,000
Closed -$230K – 334
2022
Q1 		$230K Hold
3,000
– – 0.02% 268
2021
Q4 		$230K Hold
3,000
– – 0.02% 267
2021
Q3 		$221K Hold
3,000
– – 0.02% 255
2021
Q2 		$200K Hold
3,000
– – 0.02% 261
2021
Q1 		$223K Buy
+3,000
New +$228K 0.02% 252

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Shufro Rose & Co's HOLX Position: Q2 2022 in Review

Shufro Rose & Co sold out of Hologic (HOLX) in Q2 2022, closing a stake of 3,000 shares — an estimated $230K sold.

Shufro Rose & Co first reported a position in HOLX in Q1 2021 and held it in 5 quarters. The position peaked at $230K in Q1 2022. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Shufro Rose & Co reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Shufro Rose & Co sold 3,000 Hologic shares in Q2 2022, an estimated $230K.
  • Shufro Rose & Co first reported a position in Hologic in Q1 2021 and held it in 5 quarters.
  • Shufro Rose & Co's Hologic position peaked at $230K in Q1 2022.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Shufro Rose & Co's 13F filing for Q2 2022, filed 22 Jul 2022.